Abstract
Congenital cytomegalovirus (CMV) infection is a major cause of birth defects and childhood disorders in the United States. Retinitis occurs in 25% of infants with severely symptomatic congenital CMV and in ∼1% of asymptomatic infants. Intravitreal ganciclovir is recommended in adults with CMV retinitis (CMVR) refractory or noncompliant to intravenous therapy. No literature is available discussing the use of intravitreal ganciclovir for CMVR in neonates. We report a term neonate who received intravenous and intravitreal ganciclovir for treatment of CMVR. Three doses of intravitreal ganciclovir (2 mg per dose in each eye) were administered. Intravitreal injections of ganciclovir appeared to be well tolerated and improvement of the retinitis was appreciated. Intravitreal ganciclovir is an effective treatment of CMVR in adult acquired immunodeficiency syndrome (AIDS) patients. We report one case of intravitreal ganciclovir in a term neonate with promising results.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Stagno S, Pass RF, Dworsky ME, Alford CA . Congenital and perinatal CMV infections. Semin Perinatol 1983; 7: 31–34.
Istas AS, Demmler GJ, Dobbins JG, Stewart JA The National Congenital CMV Disease Registry Collaborating Group. Surveillance for CMV disease: a report from the National Congenital CMV disease registry. Clin Infect Dis 1995; 20: 665–70.
Young S, Morlet N, Besen G, Wiley CA, Jones P, Gold J . High dose (2000 mcg) intravitreous ganciclovir in the treatment of cytomegalovirus retinitis. Ophthalmology 1998; 105: 1404–10.
Holland G, Sidikaro Y, Kreiger A, Hardy D, Sakamoto MJ, Frenkel LM et al. Treatment of cytomegalovirus retinopathy with ganciclovir. Ophthalmology 1987; 94: 815–23.
Smith CL . Local therapy for cytomegalovirus retinitis. Ann Pharmacother 1998; 32 (2): 248–55.
Harris ML, Mathalone MBR . Intravitreal ganciclovir in CMV retinitis: case report. Br J Ophthalmol 1989; 73: 382–84.
Cantrill HL, Henry K, Melroe NH, Knoblock WH, Ramsay RC, Baljour HH . Treatment of cytomegalovirus retinitis with intravitreal ganciclovir. Long term results. Ophthalmology 1989; 96: 367–74.
Heinemann MH . Long term intravitreal ganciclovir therapy for cytomegalovirus retinopathy. Arch Ophthalmol 1989; 107: 1767–72.
Cochereau-Massin I, Lehoang P, Lautier-Frau M, Zazoun L, Marcel P, Robinet M et al. Efficacy and tolerance of intravitreal ganciclovir in cytomegalovirus retinitis in acquired immune deficiency syndrome. Ophthalomology 1991; 98: 1348–55.
Committee on Infectious Diseases Cytomegalovirus Infection. In: Red Book 2006 Report on the Committee of Infectious Diseases 27th edition Elk Grove Village, IL, USA: American Academy of Pediatrics; 2006, pp 273–77.
Kimberlin DW, Lin CY, Sanchez PJ, Demmerl GJ, Danker W, Shelton M et al. Effect of ganciclovir on hearing in symptomatic congenital cytomegalovirus disease involving the central nervous system: a randomized, controlled trial. J Pediatr 2003; 143: 16–25.
Coats DK, Demmler GJ, Ea Paysse, Du LT, Libby C . Ophthalmologic findings in children with congenital cytomegalovirus infections. J AAPOS 2000; 4: 110–16.
Teoh SC, Ou X, Lim TH . Intravitreal ganciclovir maintenance injection for cytomegalovirus retinitis: efficacy of a low volume, intermediate dose regimen. Ophthalmology 2012; 119 (3): 588–95.
Mota A, Breda J, Silva R, Magalhães A, Falcão-Reis F . Cytomegalovirus Retinitis in an immunocompromised infant: a case report and review of the literature. Case Rep Ophthalmol 2011; 2: 238–42.
Hayden FG . Antireroviral agents (Nonretroviral) In: Brunton LB, Lazo JS, Parker KL, eds. Goodman & Gilman's The Pharmacological Basis of Therapeutics 11th ed. New York: McGraw-Hill, 2005 pp 1254–1255.
Arevalo JF, Gonzalez C, Capparelli EV, Kirsch LS, Garcia RF, Quiceno JI et al. Intravitreous and plasma concentrations of ganciclovir and foscarnet after intravenous therapy in patients with AIDS and cytomegalovirus retinitis. J Infect Dis 1995; 172: 951–6.
Morlet N, Young S, Naidoo D, Graham G, Coroneo MT . High dose intravitreal ganciclovir injection provides a prolonged therapeutic intraoccuar concentration. Br J Ophthalmol 1996; 80: 214–6.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no conflict of interest.
Rights and permissions
About this article
Cite this article
Oschman, A., Murthy, V., Kollipara, R. et al. Intravitreal Ganciclovir for Neonatal Cytomegalovirus-Associated Retinitis: A Case Report. J Perinatol 33, 329–331 (2013). https://doi.org/10.1038/jp.2012.139
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/jp.2012.139
This article is cited by
-
Good syndrome and other causes of cytomegalovirus retinitis in HIV-negative patients—case report and comprehensive review of the literature
Journal of Ophthalmic Inflammation and Infection (2016)